CollPlant Biotechnologies Ltd — Form SCHEDULE 13D/A
Filed July 27, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
Lilian S. Loewenbaum filed an amended Schedule 13D/A disclosing beneficial ownership in CollPlant Biotechnologies Ltd (Israeli biotech, SIC 3842 orthopedic/surgical supplies). The filing is dated 2026-07-27. The document text itself does not provide specific share counts, percentages, dollar amounts, or details of what changed from the prior 13D filing—only that this is an amendment.
Why this rating
Amendment to ownership disclosure is routine SEC filing; no material transaction, operational change, or quantified ownership shift disclosed in available text.
See more from July 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.